LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has introduced Acetylcysteine Solution, USP, 10% in multiple presentations – 4 mL, 10 mL and 30 mL vials – with immediate ...
Aug. 7 -- Abraxis BioScience, Inc., an integrated, global biopharmaceutical company, today announced that its hospital-based products business, Abraxis Pharmaceutical Products (APP), has received ...
The company is voluntarily recalling all lots of Adrenalin Chloride Solution (EPINEPHrine nasal solution, USP) 30 mg/30 mL (1 mg/mL) 30 mL vials due to misleading labeling and its status as an ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi USA announced today it has launched for immediate availability Acetylcysteine Solution, USP, 20% 4 mL vial for inhalation (mucolytic agent) or oral ...